Figure 2From: Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial Mean suicidal score unadjusted (a) and adjusted (b) from baseline score for escitalopram and nortriptyline for the 12 weeks of follow-up. Panels (c) and (d) display the baseline-adjusted mean suicidal score for men and women, respectively, during the 12 weeks of follow-up.Back to article page